Sun Pharma bets big on emerging markets

  • 2:03
  • Published On: July 29, 2011
Cinema View
Embed
India's largest drug firm by market capitalisation Sun Pharma is looking at emerging markets and is also eyeing an acquisition with Rs 4500 crore surplus in its kitty.

Related Videos

Sun Pharma Q4 Profit In Line With Estimates
May 26, 2023 0:35
Drug Major Sun Pharma Hit By Ransomware Attack
March 27, 2023 1:53
Shanghai Eases Covid Restrictions: Why This Impacts The World
May 31, 2022 2:02
Shanghai Back In Business As Covid Curbs Eased
May 31, 2022 8:01
Global Economy: Challenges Of Rising Nationalism
February 25, 2019 24:10
Nifty Hits 11,600, Sensex Opens Above 38,400 For First Time
August 23, 2018 0:41
Let's Get Ties On 'Right Track', China's Xi Jinping Tells PM Narendra Modi
September 05, 2017 1:55
PM Narendra Modi's Speech At BRICS Emerging Markets and Developing Countries Dialogue
September 05, 2017 8:32
Sensex, Nifty Open On A Flat Note
July 05, 2017 1:45
Sensex Opens On Weak Note, Sun Pharma Shares Outperform
June 30, 2017 3:14
RIL, Bank Of Baroda, SBI Among Top Picks: Niraj Dalal
February 08, 2017 34:50
Accumulate Pharma Stocks: Sajiv Dhawan
November 10, 2016 35:15
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination